Investigating the impact of respiratory viruses on adults in India
RFA-IP-22-001 - Burden and sequelae of influenza, SARS-CoV-2 and other respiratory viruses associated Severe Acute Respiratory Infections among Indian adult population aged 18-60yrs
This study is looking at how influenza and COVID-19 affect working adults in India, including how often these illnesses occur, the costs of treatment, and how well vaccines work, while also understanding why some healthcare workers might be hesitant to get vaccinated, all to help improve public health in the future.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | All-India Institute of Medical Sciences NIH-funded |
| Lab location | 1 site (New Delhi, India) |
| Project ID | NIH-10916158 on NIH RePORTER |
What this research studies
This research focuses on understanding the burden and long-term effects of influenza and SARS-CoV-2 infections among working adults in India aged 18-60. It aims to estimate the incidence and treatment costs associated with severe acute respiratory infections (SARI) and to assess the effectiveness of vaccines against these viruses. The study will also explore vaccine hesitancy among healthcare workers and develop strategies for public health interventions. By establishing a national registry and network of hospitals, the research seeks to provide valuable data for evidence-based policy development.
Who could benefit from this research
Good fit: Ideal candidates for participation are adults aged 18-60 who have experienced severe acute respiratory infections or are healthcare workers involved in vaccination efforts.
Not a fit: Patients outside the age range of 18-60 or those with mild respiratory infections may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved public health policies and better management of respiratory infections, ultimately reducing the economic burden on the adult population in India.
How similar studies have performed: Previous research has shown success in understanding the impact of respiratory viruses in various populations, making this approach both relevant and necessary.
Where this research is happening
New Delhi, India
- All-India Institute of Medical Sciences — New Delhi, India (Active)
Researchers
- Principal investigator: Krishnan, Anand — All-India Institute of Medical Sciences
- Study coordinator: Krishnan, Anand
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.